ADMA vs. UPXI

Last updated Jul 11, 2026

ADMA (ADMA Biologics, Inc.) and UPXI (Upexi Inc.) are both stocks. ADMA operates in Biotechnology (Healthcare), while UPXI operates in Internet Content & Information (Communication Services). Over the past 5 years, ADMA returned 43.35%/yr vs -61.97%/yr for UPXI. At a 0.12 correlation, their price movements are largely independent.

Performance

ADMA vs. UPXI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ADMA Biologics, Inc. (ADMA) and Upexi Inc. (UPXI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both stocks are quite close, with ADMA having a -50.22% return and UPXI slightly lower at -50.60%.

ADMA

• 1D: -2.05%
• 1M: 10.60%
• 6M: -49.42%
• YTD: -50.22%
• 1Y: -50.95%
• 3Y*: 36.76%
• 5Y*: 43.35%
• 10Y*: 1.98%

UPXI

• 1D: 1.53%
• 1M: -8.81%
• 6M: -60.85%
• YTD: -50.60%
• 1Y: -84.60%
• 3Y*: -73.58%
• 5Y*: -61.97%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ADMA vs. UPXI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ADMA ADMA Biologics, Inc.	-50.22%	6.36%	279.42%	16.49%	175.18%	-15.06%
UPXI Upexi Inc.	-50.60%	-52.14%	-84.87%	-61.33%	-25.37%	-19.60%

Correlation

The correlation between ADMA and UPXI is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.20
Correlation (3Y) Calculated over the trailing 3-year period	0.13
Correlation (5Y) Calculated over the trailing 5-year period	0.11
Correlation (All Time) Calculated using the full available price history since Jun 24, 2021	0.12

Fundamentals

Market Cap ADMA : $2.10B UPXI : $58.32M
EPS ADMA : $0.68 UPXI : -$3.19
PS Ratio ADMA : 4.32 UPXI : 2.27
Total Revenue (TTM) ADMA : $509.86M UPXI : $26.14M
Gross Profit (TTM) ADMA : $312.42M UPXI : $22.60M
EBITDA (TTM) ADMA : $218.74M UPXI : -$52.70M

Return for Risk

ADMA vs. UPXI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADMA

ADMA Risk / Return Rank: 9
ADMA Sharpe Ratio Rank: 7
ADMA Sortino Ratio Rank: 9
ADMA Omega Ratio Rank: 8
ADMA Calmar Ratio Rank: 12
ADMA Martin Ratio Rank: 6

UPXI

UPXI Risk / Return Rank: 13
UPXI Sharpe Ratio Rank: 17
UPXI Sortino Ratio Rank: 11
UPXI Omega Ratio Rank: 16
UPXI Calmar Ratio Rank: 8
UPXI Martin Ratio Rank: 16

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ADMA vs. UPXI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Upexi Inc. (UPXI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ADMA	UPXI	Difference
Sharpe ratio: Return per unit of total volatility	-0.94	-0.62	-0.32
Sortino ratio: Return per unit of downside risk	-1.27	-1.14	-0.13
Omega ratio: Gain probability vs. loss probability	0.83	0.89	-0.06
Calmar ratio: Return relative to maximum drawdown	-0.81	-0.89	+0.08
Martin ratio: Return relative to average drawdown	-1.51	-1.20	-0.31

ADMA vs. UPXI - Sharpe Ratio Comparison

The current ADMA Sharpe Ratio is -0.94, which is lower than the UPXI Sharpe Ratio of -0.62. The chart below compares the historical Sharpe Ratios of ADMA and UPXI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ADMA vs. UPXI - Drawdown Comparison

The maximum ADMA drawdown since its inception was -91.28%, smaller than the maximum UPXI drawdown of -99.64%. Use the drawdown chart below to compare losses from any high point for ADMA and UPXI.

Drawdown Indicators

	ADMA	UPXI	Difference
Max Drawdown Largest peak-to-trough decline	-91.28%	-99.64%	+8.36%
Max Drawdown (1Y) Largest decline over 1 year	-62.71%	-93.39%	+30.68%
Max Drawdown (3Y) Largest decline over 3 years	-68.99%	-98.77%	+29.78%
Max Drawdown (5Y) Largest decline over 5 years	-68.99%	-99.63%	+30.64%
Max Drawdown (10Y) Largest decline over 10 years	-86.11%	—	—
Current Drawdown Current decline from peak	-62.95%	-99.47%	+36.52%
Average Drawdown Average peak-to-trough decline	-53.11%	-73.21%	+20.10%
Ulcer Index Depth and duration of drawdowns from previous peaks	33.77%	69.55%	-35.78%

Volatility

ADMA vs. UPXI - Volatility Comparison

The current volatility for ADMA Biologics, Inc. (ADMA) is 10.37%, while Upexi Inc. (UPXI) has a volatility of 31.92%. This indicates that ADMA experiences smaller price fluctuations and is considered to be less risky than UPXI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ADMA	UPXI	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.37%	31.92%	-21.55%
Volatility (6M) Calculated over the trailing 6-month period	45.81%	94.09%	-48.28%
Volatility (1Y) Calculated over the trailing 1-year period	54.24%	136.86%	-82.62%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	59.40%	202.47%	-143.07%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	68.97%	202.64%	-133.67%

Dividends

ADMA vs. UPXI - Dividend Comparison

Neither ADMA nor UPXI has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ADMA and UPXI in my portfolio?

ADMA and UPXI have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ADMA or UPXI?

UPXI has higher volatility (31.92%) compared to ADMA (10.37%). In terms of maximum drawdown, ADMA dropped -91.28% vs UPXI's -99.64%.

Which has better risk-adjusted returns?

UPXI currently has the higher Sharpe Ratio (-0.62 vs -0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.